We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+14.31%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$31.8B
AUM Growth
+$3.15B
(+11%)
Cap. Flow
-$526M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
53.35%
Holding
72
New
19
Increased
19
Reduced
27
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$542M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$234M |
| 3 |
Snap
SNAP
|
+$233M |
| 4 |
Shopify
SHOP
|
+$221M |
| 5 |
Netflix
NFLX
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$385M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
+$306M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$237M |
| 4 |
Visa
V
|
+$180M |
| 5 |
CERN
Cerner Corp
CERN
|
+$148M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.99% |
| 2 | Communication Services | 21.5% |
| 3 | Healthcare | 17.27% |
| 4 | Technology | 16.38% |
| 5 | Financials | 12.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Visa
V
$703B
| $2.64B | 8.28% |
29,667,052
-2,092,757
| -7% | -$180M |
|
2
Meta Platforms (Facebook)
META
$1.49T
| $2.29B | 7.19% |
16,124,212
-723,282
| -4% | -$96.7M |
|
3
Booking.com
BKNG
$154B
| $2.14B | 6.71% |
30,015,700
-1,291,550
| -4% | -$85.2M |
|
4
Amazon
AMZN
$2.45T
| $1.93B | 6.07% |
43,608,680
-2,139,100
| -5% | -$89.1M |
|
5
Alibaba
BABA
$273B
| $1.86B | 5.84% |
17,253,355
-428,503
| -2% | -$43.6M |
|
6
Alphabet (Google) Class A
GOOGL
$4.07T
| $1.33B | 4.18% |
31,388,360
-1,341,040
| -4% | -$56.4M |
|
7
Salesforce
CRM
$152B
| $1.28B | 4.03% |
15,566,873
-1,098,613
| -7% | -$87.8M |
|
|
8
Netflix
NFLX
$300B
| $1.19B | 3.74% |
80,529,640
+15,713,470
| +24% | +$220M |
|
|
SCHW
9
Charles Schwab
SCHW
$184B
| $1.19B | 3.74% |
29,154,298
-1,118,527
| -4% | -$46.2M |
|
|
10
Regeneron Pharmaceuticals
REGN
$73.3B
| $1.14B | 3.57% |
2,933,444
+630,642
| +27% | +$234M |
|
11
Baidu
BIDU
$35.4B
| $1.1B | 3.45% |
6,365,329
-193,147
| -3% | -$34M |
|
12
Adobe
ADBE
$104B
| $1.04B | 3.27% |
8,012,336
-538,772
| -6% | -$63.2M |
|
13
Illumina
ILMN
$29.1B
| $938M | 2.94% |
5,649,136
-224,021
| -4% | -$35.3M |
|
14
BioMarin Pharmaceuticals
BMRN
$12B
| $788M | 2.47% |
8,972,405
-408,397
| -4% | -$36.3M |
|
15
Edwards Lifesciences
EW
$48.9B
| $753M | 2.37% |
24,021,609
-960,405
| -4% | -$30.1M |
|
16
Chipotle Mexican Grill
CMG
$43.6B
| $708M | 2.22% |
79,484,350
-3,931,250
| -5% | -$32.4M |
|
17
Biogen
BIIB
$31.8B
| $677M | 2.13% |
2,475,937
-102,972
| -4% | -$29.1M |
|
|
18
Alphabet (Google) Class C
GOOG
$4.06T
| $674M | 2.12% |
16,241,680
-181,660
| -1% | -$7.45M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
| $635M | 1.99% |
5,235,630
-349,638
| -6% | -$45.1M |
|
20
ASML
ASML
$592B
| $604M | 1.9% |
4,550,006
+7,500
| +0.2% | +$922K |
|
|
SPLK
21
DELISTED
Splunk Inc
SPLK
| $590M | 1.85% |
9,467,334
-618,923
| -6% | -$37M |
|
22
Monster Beverage
MNST
$96.5B
| $572M | 1.79% |
24,757,190
-939,242
| -4% | -$21M |
|
23
Incyte
INCY
$25.5B
| $568M | 1.78% |
4,250,593
+597,941
| +16% | +$76.1M |
|
|
24
Starbucks
SBUX
$118B
| $560M | 1.76% |
+9,583,025
| New | +$542M |
|
25
Workday
WDAY
$41B
| $473M | 1.49% |
5,681,570
+4,900
| +0.1% | +$407K |
|
Similar funds
KK
VAI
UIM
SO
Sands Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Sands Capital Management held 72 positions worth $31.8B, up 11% from $28.7B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Sands Capital Management's Q1 2017 filing shows 19 new, 19 increased, 27 reduced and 5 closed positions. Its largest new stake was Starbucks: 9,583,025 shares worth $560M. The largest sale was Monsanto Co, an estimated $385M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.
- Sands Capital Management's largest Q1 2017 buy was Starbucks: 9,583,025 shares worth $560M.
- Sands Capital Management added most to Regeneron Pharmaceuticals in Q1 2017, an estimated $234M increase.
- Sands Capital Management's biggest Q1 2017 reduction was Visa, cutting an estimated $180M.
- Sands Capital Management fully exited Monsanto Co in Q1 2017, selling an estimated $385M.
- Sands Capital Management's ten largest holdings make up 53% of its $31.8B portfolio in Q1 2017.
- Sands Capital Management opened 19 new positions and closed 5 in Q1 2017.
- Sands Capital Management's portfolio value rose 11% quarter-over-quarter to $31.8B.
Based on Sands Capital Management's 13F filing for Q1 2017, filed 12 May 2017.